Supplemental Guarantor Information (Condensed Consolidating Statement Of Cash Flows) (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
OPERATING ACTIVITIES:
Net cash (used in) provided by operating activities	$ (58,747)	$ (13,062)
INVESTING ACTIVITIES:
Purchases of property, plant and equipment	(23,956)	(29,112)
Proceeds from sale of property, plant and equipment	311	191
Acquisitions, net of cash acquired	(3,645)	0
Patent acquisition costs and license fees	(10,000)	(5,000)
Net cash used in investing activities	(37,290)	(33,921)
FINANCING ACTIVITIES:
Capital lease obligations repayments	(89)	(127)
Direct financing arrangement repayments	(857)	0
Proceeds from other indebtedness	223	0
Principal payments on Term Loans	(100,000)	(219,063)
Deferred financing fees	(7,251)	0
Payment for contingent consideration	(5,000)	0
Principal payments on other indebtedness	0	(439)
Tax benefits of stock awards	1,998	3,521
Exercise of Endo Health Solutions Inc. stock options	12,826	9,543
Purchase of common stock	0	(33,000)
Issuance of common stock from treasury	1,557	1,412
Cash distributions to noncontrolling interests	(12,832)	(13,120)
Cash buy-out of noncontrolling interests, net of cash contributions	(1,525)	(849)
Intercompany activity	0	0
Net cash provided by (used in) financing activities	(110,950)	(252,122)
Effect of foreign exchange rate	(412)	(212)
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	(207,399)	(299,317)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	547,916	547,620
CASH AND CASH EQUIVALENTS, END OF PERIOD	340,517	248,303
Endo Health Solutions Inc. [Member]
OPERATING ACTIVITIES:
Net cash (used in) provided by operating activities	(3,316)	1,398
INVESTING ACTIVITIES:
Purchases of property, plant and equipment	0	0
Proceeds from sale of property, plant and equipment	0	0
Acquisitions, net of cash acquired	0
Patent acquisition costs and license fees	0	0
Net cash used in investing activities	0	0
FINANCING ACTIVITIES:
Capital lease obligations repayments	0	0
Direct financing arrangement repayments	0
Proceeds from other indebtedness	0
Principal payments on Term Loans	(100,000)	(219,063)
Deferred financing fees	(7,251)
Payment for contingent consideration	0
Principal payments on other indebtedness		0
Tax benefits of stock awards	0	0
Exercise of Endo Health Solutions Inc. stock options	12,826	9,543
Purchase of common stock		(33,000)
Issuance of common stock from treasury	1,557	1,412
Cash distributions to noncontrolling interests	0	0
Cash buy-out of noncontrolling interests, net of cash contributions	0	0
Intercompany activity	96,422	232,438
Net cash provided by (used in) financing activities	3,554	(8,670)
Effect of foreign exchange rate	0	0
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	238	(7,272)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	512	48,318
CASH AND CASH EQUIVALENTS, END OF PERIOD	750	41,046
Guarantor Subsidiaries [Member]
OPERATING ACTIVITIES:
Net cash (used in) provided by operating activities	(52,701)	58,035
INVESTING ACTIVITIES:
Purchases of property, plant and equipment	(20,935)	(27,580)
Proceeds from sale of property, plant and equipment	20
Acquisitions, net of cash acquired
Patent acquisition costs and license fees	(10,000)	(5,000)
Net cash used in investing activities	(30,915)	(32,580)
FINANCING ACTIVITIES:
Capital lease obligations repayments	(39)	(127)
Direct financing arrangement repayments	(857)
Proceeds from other indebtedness
Principal payments on Term Loans	0	0
Deferred financing fees
Payment for contingent consideration	(5,000)
Principal payments on other indebtedness		0
Tax benefits of stock awards	1,998	3,521
Exercise of Endo Health Solutions Inc. stock options	0	0
Purchase of common stock		0
Issuance of common stock from treasury	0	0
Cash distributions to noncontrolling interests	0	0
Cash buy-out of noncontrolling interests, net of cash contributions	0	0
Intercompany activity	(113,246)	(318,552)
Net cash provided by (used in) financing activities	(117,144)	(315,158)
Effect of foreign exchange rate	0	0
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	(200,760)	(289,703)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	499,932	455,756
CASH AND CASH EQUIVALENTS, END OF PERIOD	299,172	166,053
Non-Guarantor Subsidiaries [Member]
OPERATING ACTIVITIES:
Net cash (used in) provided by operating activities	(2,730)	(72,495)
INVESTING ACTIVITIES:
Purchases of property, plant and equipment	(3,021)	(1,532)
Proceeds from sale of property, plant and equipment	291	191
Acquisitions, net of cash acquired	(3,645)
Patent acquisition costs and license fees	0	0
Net cash used in investing activities	(6,375)	(1,341)
FINANCING ACTIVITIES:
Capital lease obligations repayments	(50)	0
Direct financing arrangement repayments	0
Proceeds from other indebtedness	223
Principal payments on Term Loans	0	0
Deferred financing fees	0
Payment for contingent consideration	0
Principal payments on other indebtedness		(439)
Tax benefits of stock awards	0
Exercise of Endo Health Solutions Inc. stock options	0	0
Purchase of common stock		0
Issuance of common stock from treasury	0	0
Cash distributions to noncontrolling interests	(12,832)	(13,120)
Cash buy-out of noncontrolling interests, net of cash contributions	(1,525)	(849)
Intercompany activity	16,824	86,114
Net cash provided by (used in) financing activities	2,640	71,706
Effect of foreign exchange rate	(412)	(212)
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	(6,877)	(2,342)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	47,472	43,546
CASH AND CASH EQUIVALENTS, END OF PERIOD	40,595	41,204
Eliminations [Member]
OPERATING ACTIVITIES:
Net cash (used in) provided by operating activities	0	0
INVESTING ACTIVITIES:
Purchases of property, plant and equipment	0	0
Proceeds from sale of property, plant and equipment	0	0
Acquisitions, net of cash acquired	0
Patent acquisition costs and license fees	0	0
Net cash used in investing activities	0
FINANCING ACTIVITIES:
Capital lease obligations repayments	0	0
Direct financing arrangement repayments	0
Proceeds from other indebtedness	0
Principal payments on Term Loans	0	0
Deferred financing fees	0
Payment for contingent consideration	0
Principal payments on other indebtedness		0
Tax benefits of stock awards	0	0
Exercise of Endo Health Solutions Inc. stock options	0	0
Purchase of common stock		0
Issuance of common stock from treasury	0	0
Cash distributions to noncontrolling interests	0	0
Cash buy-out of noncontrolling interests, net of cash contributions	0	0
Intercompany activity	0
Net cash provided by (used in) financing activities	0
Effect of foreign exchange rate	0	0
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	0	0
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	0	0
CASH AND CASH EQUIVALENTS, END OF PERIOD	$ 0	$ 0